• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在中国的一个单中心回顾性研究中,探讨了房颤患者血栓形成的危险因素和导管消融对反复血栓形成的影响。

The risk factors of thrombus formation and the effect of catheter ablation on repetitive thrombus formation in patients with atrial fibrillation: a single center retrospective study in China.

机构信息

The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.

Department of Cardiology, Nanyang Central Hospital, Nanyang, China.

出版信息

BMC Cardiovasc Disord. 2023 Jan 17;23(1):28. doi: 10.1186/s12872-023-03050-z.

DOI:10.1186/s12872-023-03050-z
PMID:36650447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9843887/
Abstract

BACKGROUND

Atrial fibrillation (AF) predisposes patients to the formation of atrial thrombi. The CHADS-VASc score does not include all risk factors for atrial thrombosis. The present study is designed to explore the influencing factors of thrombus formation in patients with AF and to investigate the effect of catheter ablation (CA) on recurrent thrombosis in patients with a history of intracardiac thrombus.

METHODS

(1) This study consisted of 1726 patients that underwent CA, among which 58 patients had a history of intracardiac thrombus prior to CA. The risk factors for thrombus formation were explored by comparing the baseline clinical characteristics of patients with and without atrial thrombus. (2) The left atrial appendage flow velocity (LAAFV) in patients with a history of intracardiac thrombus who were willing to undergo transesophageal echocardiography (TEE) at the latest follow-up were examined, and comparisons of the LAAFV was made before and after CA.

RESULTS

The median follow-up period is 13 months. Persistent AF was found to be the only independent risk factor affecting the formation of atrial thrombus among the investigated factors (OR 3.152; 95%CI 1.806-5.500; p < 0.001). Twenty-seven patients agreed to undergo TEE during follow-up, no clinical ischemic stroke events were recorded, no recurrent intracardiac thrombus formation was detected in patients, 15 patients maintained sinus rhythm (55.6%) during follow-up; successful CA significantly increased LAAFV (difference between latest evaluation prior to CA 17.46 ± 14.81 cm/s, p < 0.001).

CONCLUSIONS

Persistent AF is the only independent risk factor for thrombus formation. Successful CA may improve the LAAFV and thereby decrease the risk of intracardiac thrombus formation.

摘要

背景

心房颤动(AF)使患者容易形成心房血栓。CHADS-VASc 评分并未包含所有导致心房血栓的危险因素。本研究旨在探讨 AF 患者血栓形成的影响因素,并研究导管消融(CA)对既往有心脏内血栓史患者复发性血栓形成的影响。

方法

(1)本研究纳入了 1726 例行 CA 的患者,其中 58 例患者在 CA 前有心脏内血栓史。通过比较有和无心房血栓患者的基线临床特征,探讨血栓形成的危险因素。(2)对愿意在最新随访时行经食管超声心动图(TEE)检查的既往有心脏内血栓史患者的左心耳血流速度(LAAFV)进行检测,并比较 CA 前后的 LAAFV。

结果

中位随访时间为 13 个月。持续性 AF 是唯一影响心房血栓形成的独立危险因素(OR 3.152;95%CI 1.806-5.500;p<0.001)。27 例患者在随访期间同意行 TEE,未记录到临床缺血性脑卒中事件,未发现患者有复发性心脏内血栓形成,15 例患者在随访期间维持窦性心律(55.6%);成功的 CA 显著增加了 LAAFV(CA 前最新评估时的差值为 17.46±14.81 cm/s,p<0.001)。

结论

持续性 AF 是血栓形成的唯一独立危险因素。成功的 CA 可能会改善 LAAFV,从而降低心脏内血栓形成的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb8/9843887/7f645ade64ad/12872_2023_3050_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb8/9843887/fdeb5db18ece/12872_2023_3050_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb8/9843887/b62a14506c31/12872_2023_3050_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb8/9843887/7f645ade64ad/12872_2023_3050_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb8/9843887/fdeb5db18ece/12872_2023_3050_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb8/9843887/b62a14506c31/12872_2023_3050_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bb8/9843887/7f645ade64ad/12872_2023_3050_Fig3_HTML.jpg

相似文献

1
The risk factors of thrombus formation and the effect of catheter ablation on repetitive thrombus formation in patients with atrial fibrillation: a single center retrospective study in China.在中国的一个单中心回顾性研究中,探讨了房颤患者血栓形成的危险因素和导管消融对反复血栓形成的影响。
BMC Cardiovasc Disord. 2023 Jan 17;23(1):28. doi: 10.1186/s12872-023-03050-z.
2
Predictors for reduced flow velocity in left atrial appendage during sinus rhythm in patients with atrial fibrillation.预测心房颤动患者窦性心律时左心耳血流速度降低的因素。
Heart Vessels. 2021 Mar;36(3):393-400. doi: 10.1007/s00380-020-01702-0. Epub 2020 Sep 24.
3
Left atrial appendage flow velocity after successful ablation of persistent atrial fibrillation: clinical perspective from transesophageal echocardiographic assessment during sinus rhythm.持续性心房颤动成功消融术后左心耳血流速度:窦性心律时经食管超声心动图评估的临床视角
Am Heart J. 2015 Feb;169(2):211-21. doi: 10.1016/j.ahj.2014.11.009. Epub 2014 Nov 15.
4
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study.左心耳血流速度对心房颤动伴左心耳血栓患者血栓溶解和临床结局的影响:来自 LAT 研究的观察。
Europace. 2024 May 2;26(5). doi: 10.1093/europace/euae120.
5
Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation.房颤患者的左心耳形态复杂及左心耳血栓形成。
Circ Cardiovasc Imaging. 2014 Mar;7(2):337-43. doi: 10.1161/CIRCIMAGING.113.001317. Epub 2014 Feb 12.
6
Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.在接受利伐沙班不间断治疗的心房颤动消融患者中,经食管超声心动图与心内超声心动图筛查的比较
BMC Cardiovasc Disord. 2017 Jun 29;17(1):171. doi: 10.1186/s12872-017-0607-1.
7
Transoesophageal echocardiography prior to catheter ablation could be avoided in atrial fibrillation patients with a low risk of stroke and without filling defects in the late-phase MDCT scan: A retrospective analysis of 783 patients.经食管超声心动图在导管消融前可避免在低卒中风险且 MDCT 晚期扫描无充盈缺损的房颤患者中进行:783 例患者的回顾性分析。
Eur Radiol. 2018 May;28(5):1835-1843. doi: 10.1007/s00330-017-5172-6. Epub 2017 Dec 7.
8
Left atrial appendage orifice area and morphology is closely associated with flow velocity in patients with nonvalvular atrial fibrillation.左心耳口面积和形态与非瓣膜性心房颤动患者的血流速度密切相关。
BMC Cardiovasc Disord. 2021 Sep 16;21(1):442. doi: 10.1186/s12872-021-02242-9.
9
Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias.出乎意料的是,在电隔离左心耳以治疗房性心动过速后,中风和左心耳血栓形成的发生率很高。
Circ Arrhythm Electrophysiol. 2016 May;9(5):e003461. doi: 10.1161/CIRCEP.115.003461.
10
Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography.心房颤动导管消融术前左心耳血栓患者的风险分层:一种个体化使用经食管超声心动图的方法。
J Cardiovasc Electrophysiol. 2017 Oct;28(10):1127-1136. doi: 10.1111/jce.13279. Epub 2017 Jul 26.

引用本文的文献

1
Digital twin integrating clinical, morphological and hemodynamic data to identify stroke risk factors.整合临床、形态学和血流动力学数据以识别中风风险因素的数字孪生模型。
NPJ Digit Med. 2025 Jun 17;8(1):369. doi: 10.1038/s41746-025-01676-1.
2
Association Between the Timing of Atrial Fibrillation Detection and Functional Outcome Following Mechanical Thrombectomy.机械取栓后心房颤动检测时间与功能结局的关系。
J Am Heart Assoc. 2024 Sep 3;13(17):e034861. doi: 10.1161/JAHA.124.034861. Epub 2024 Aug 27.

本文引用的文献

1
Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China.中国成年人全国性调查中的房颤患病率、知晓率及管理情况
Heart. 2021 Jan 28;107(7):535-41. doi: 10.1136/heartjnl-2020-317915.
2
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.心脏病与中风统计-2021 更新:美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
3
Thromboembolic Risk of Cessation of Oral Anticoagulation Post Catheter Ablation in Patients With and Without Atrial Fibrillation Recurrence.
口服抗凝药物停药后导管消融患者伴或不伴心房颤动复发的血栓栓塞风险。
Am J Cardiol. 2020 Dec 15;137:55-62. doi: 10.1016/j.amjcard.2020.09.036. Epub 2020 Sep 28.
4
Prevalence and risk factors of left atrial thrombus in patients with atrial fibrillation and lower class (IIa) recommendation to anticoagulants.心房颤动患者左心房血栓的患病率及危险因素与抗凝治疗的Ⅱa类推荐
Cardiovasc Diagn Ther. 2020 Aug;10(4):717-724. doi: 10.21037/cdt-20-151.
5
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
6
Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.心房颤动与血栓前状态:2020 年再探维柯氏三联征。
Heart. 2020 Oct;106(19):1463-1468. doi: 10.1136/heartjnl-2020-316977. Epub 2020 Jul 16.
7
The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study.显然成功的心房颤动消融术后停止口服抗凝治疗的安全性:来自中国心房颤动登记研究的报告。
Europace. 2020 Jan 1;22(1):90-99. doi: 10.1093/europace/euz235.
8
Usefulness of transesophageal echocardiography before cardioversion in atrial arrhythmias.经食管超声心动图在心房颤动转复前的应用价值。
Cardiol J. 2021;28(1):101-109. doi: 10.5603/CJ.a2019.0056. Epub 2019 Jun 21.
9
Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.心房颤动类型和肾功能不全是左心房血栓的重要预测因素。
Heart. 2019 Sep;105(17):1310-1315. doi: 10.1136/heartjnl-2018-314492. Epub 2019 Apr 30.
10
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.导管消融与抗心律失常药物治疗对心房颤动患者死亡率、卒中和出血及心搏骤停的影响:CABANA 随机临床试验。
JAMA. 2019 Apr 2;321(13):1261-1274. doi: 10.1001/jama.2019.0693.